| 2D: | 2-dimensions |
| 3D: | 3-dimensions; |
| AA: | amino acids; |
| AMPK: | AMP-activated protein kinase; |
| BSA: | bovine serum albumin; |
| CH: | centesimal Hahnemannian |
| COX: | cyclooxygenase |
| CRC: | colorectal cancer; |
| CTLs: | cytotoxic T lymphocytes; |
| DNA: | deoxyribonucleic acid |
| EGF: | epidermal growth factor; |
| EGFR: | epidermal growth factor receptor |
| ELISA: | enzyme linked immunosorbent assay; |
| EMA: | European Medicines Agency; |
| ETP: | etoposide; |
| FBS: | fetal bovine serum; |
| FCS: | fetal calf serum; |
| FDA: | Food and Drug Administration; |
| FGF2: | fibroblast growth factor 2; |
| fMLP: | N-formyl methionyl-leucyl-phenylalanine; |
| GFI: | green fluorescence integral; |
| GFP: | green fluorescent protein; |
| GM-CSF: | granulocyte-macrophage colony-stimulating factor; |
| H&E: | hematoxylin and eosin; |
| HLA: | human leukocyte antigen; |
| hr: | human recombinant; |
| IFN: | interferon; |
| IHC: | immunohistochemistry; |
| ILs: | interleukins; |
| K: | Korsakovian dilution; |
| LD: | low dose; |
| LPS: | lipopolysaccharide; |
| M1: | M1 macrophage; |
| MCH: | major histocompatibility complex; |
| M-CSF: | macrophage colony-stimulating factor; |
| MI: | micro-immunotherapy; |
| MIM: | micro-immunotherapy medicine; |
| NF-κB: | nuclear factor kappa-light-chain-enhancer of activated B cells; |
| NGFI: | normalized green fluorescence intensity; |
| NK: | natural killer; |
| NMRI: | naval medical research institute; |
| NO: | nitric oxide; |
| PBMCs: | peripheral blood mononuclear cells; PBS: Phosphate buffer saline; |
| PFA: | Paraformaldehyde; |
| P/S: | penicillin/streptomycin; |
| RNA: | ribonucleic acid; |
| ROS: | reactive oxygen species; |
| RSV: | resveratrol; |
| RT: | room temperature; |
| SIRT1: | silent mating type information regulator two homolog 1; |
| SKP: | serial kinetic process; |
| SNA®: | specific nucleic acids; |
| TAMs: | tumor-associated macrophages; TARC: thymus and activation-regulated chemokine; |
| TGF-β: | transforming growth factor-β; |
| TGFBR: | transforming growth factor receptor; |
| TLR: | toll-like receptor; |
| TNF-α: | tumor necrosis factor-α; |
| TUNEL: | terminal deoxynucleotidyl transferase dUTP nick end labeling; |
| ULD: | ultra-low dose; |
| VEGF: | vascular endothelial growth factor; |
| Veh: | vehicle; |
| Wnt: | wingless-related integration site; |